VKH
RIGL icon

Virtu KCG Holdings’s Rigel Pharmaceuticals RIGL Stock Holding History

Virtu KCG Holdings’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,244
Closed -$53K – 3645
2016
Q4 		$53K Buy
+2,244
New +$64.3K ﹤0.01% 3078
2016
Q3 		– Sell
-3,916
Closed -$87K – 3401
2016
Q2 		$87K Buy
3,916
+2,567
+190% +$63.8K ﹤0.01% 2567
2016
Q1 		$28K Sell
1,349
-2,853
-68% -$70.4K ﹤0.01% 2555
2015
Q4 		$127K Sell
4,202
-3,428
-45% -$104K ﹤0.01% 2917
2015
Q3 		$188K Buy
+7,630
New +$228K ﹤0.01% 2599
2015
Q2 		– Sell
-2,410
Closed -$86K – 3685
2015
Q1 		$86K Buy
2,410
+175
+8% +$4.8K ﹤0.01% 2691
2014
Q4 		$51K Buy
2,235
+397
+22% +$8.03K ﹤0.01% 3426
2014
Q3 		$36K Sell
1,838
-3,610
-66% -$102K ﹤0.01% 3404
2014
Q2 		$197K Buy
5,448
+2,075
+62% +$70.5K ﹤0.01% 3087
2014
Q1 		$131K Buy
3,373
+468
+16% +$16.7K ﹤0.01% 3133
2013
Q4 		$82K Sell
2,905
-593
-17% -$17.4K ﹤0.01% 3495
2013
Q3 		$125K Buy
+3,498
New +$128K ﹤0.01% 3309

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Virtu KCG Holdings's RIGL Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Rigel Pharmaceuticals (RIGL) in Q1 2017, closing a stake of 2,244 shares — an estimated $53K sold.

Virtu KCG Holdings first reported a position in RIGL in Q3 2013 and held it in 12 quarters. The position peaked at $197K in Q2 2014. 99 funds tracked by Wall St. Rank hold RIGL as of Q1 2017.

  • Virtu KCG Holdings reported no remaining Rigel Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 2,244 Rigel Pharmaceuticals shares in Q1 2017, an estimated $53K.
  • Virtu KCG Holdings first reported a position in Rigel Pharmaceuticals in Q3 2013 and held it in 12 quarters.
  • Virtu KCG Holdings's Rigel Pharmaceuticals position peaked at $197K in Q2 2014.
  • 99 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.